Wat heescht "Clear"?
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Päerd Androgen Insensitivity Syndrome In Thoroughbred Variant 2 (AIS-T2)
The Androgen Insensitivity Syndrome (AIS) Thoroughbred Variant 2 DNA test is a vital tool for horse breeders and veterinarians. This genetic test identifies carriers of AIS, a condition affecting male horses' development despite normal XY chromosomes. Early detection through the AIS Thoroughbred Variant 2 test helps prevent breeding affected stallions, ensuring healthier offspring and maintaining breed integrity. Utilizing this DNA test supports informed breeding decisions and promotes the overall well-being of Thoroughbred horses. Stay ahead in equine genetics by incorporating the AIS Thoroughbred Variant 2 test into your breeding program today. Accurate and reliable, this test is essential for responsible Thoroughbred management.
Ofkierzung: AIS-T2
Analyséiert Mutatioun: AR c.2132C/T
Ierfschaft: X-Linked Rezessiv
Acronym
AIS-T2
Observéiert Frequenz
Klinesch Gravitéit
Klinesch Klassifikatioun
Endokrine Krankheeten
Analyséiert Mutatioun
AR c.2132C/T
p.(A711V)
p.(A711V)
Modus vun Ierfschaft
X-Linked Rezessiv (Komplett)
Test Zesummefaassung:
The DNA test for Androgen Insensitivity Syndrome in Thoroughbred Variant 2 (AIS) helps identify horses carrying a genetic mutation that affects sexual development. AIS causes affected horses, typically genetically male, to develop female characteristics despite having XY chromosomes. This condition can impact fertility and breeding decisions in Thoroughbred populations. Early detection through DNA testing allows breeders to make informed choices and manage affected horses appropriately. Overall, the AIS test is a valuable tool for maintaining the health and integrity of Thoroughbred bloodlines.
Verfügbar aus dem Pack: Basic
Dësen DNA Test ass abegraff ab eisem Pack Basic - an ass och Deel vun de Pak Basic, Standard, Advanced, Complete.
View DNA Test Packs →Wielt de Pack deen am Beschten Är Zucht- oder Gesondheetsstrategie vun Ären Déieren passt.
Introduction to Androgen Insensitivity Syndrome in Thoroughbred Variant 2
Androgen Insensitivity Syndrome (AIS) is a genetic condition that affects the development of sexual characteristics in individuals with XY chromosomes. In horses, particularly in the Thoroughbred breed, a specific variant known as Thoroughbred Variant 2 has been identified. This condition can have significant implications for horse breeding and performance.
Genetic Basis of AIS
AIS is caused by mutations in the androgen receptor gene, which results in a lack of response to androgens, the hormones responsible for male sexual development. In Thoroughbred Variant 2, the genetic mutation manifests in a manner that affects the horse's reproductive system and secondary sexual characteristics. Horses with this syndrome may appear externally female but possess XY chromosomes and internal male reproductive structures.
Clinical Manifestations
Horses affected by Thoroughbred Variant 2 typically display a range of clinical signs. These may include an absence of typical male reproductive organs, the presence of underdeveloped or abnormal genitalia, and a lack of behavioral traits typically associated with stallions. As a result, these horses may not be suitable for breeding purposes, leading to ethical and practical considerations in equine management.
Impact on Breeding and Performance
The presence of AIS in Thoroughbreds can significantly impact breeding programs. Understanding the genetic status of potential breeding stock is crucial for maintaining the integrity and quality of the breed. Horses identified as carriers of the AIS variant may be excluded from breeding to prevent the propagation of the condition, thus ensuring that the lineage remains strong and healthy.
Conclusioun
Androgen Insensitivity Syndrome in Thoroughbred Variant 2 is a complex genetic condition that poses unique challenges for horse owners and breeders. By understanding the genetic underpinnings and clinical manifestations of this syndrome, stakeholders can make informed decisions that promote the health and viability of Thoroughbred horses. Ongoing research and genetic testing are essential for advancing knowledge and management practices related to AIS.
Rass unerkannt fir den Test: Androgen Insensitivity Syndrome In Thoroughbred Variant 2 (AIS-T2)
- Thoroughbred
🧬 Interpretation of genotypes AIS-T2
Genotyp
Status
🟡 N/N
Net-Träger - kee Risiko
❌ ♂ N/AIS-T2
Betraff - Am Risiko
🟡 ♀ N/AIS-T2
Carrier - kee Risiko
❌ AIS-T2/AIS-T2
Betraff - Am Risiko
FAQ: d'Interpretatioun verstoen
Ass e "Carrier" eescht?
Nee D'Déier ass allgemeng gesond mee kann d'Mutatioun un seng iwwerdroen Nofolger.
Wat wann en Déier "Betraff" ass?
Et huet zwee mutéiert Exemplare. Klinesch Zeeche ginn erwaart jee no der Krankheet. Et soll net gefeelt ginn.
Firwat ginn et Ënnerscheeder tëscht männlech / weiblech?
E puer Krankheeten sinn Geschlecht verbonnen, sou datt hiren Ausdrock variéiert jee no der Geschlecht vum Déier.
Viraus Nokommen
N/N (net-trager)
N/AIS-T2 (Carrier)
AIS-T2/AIS-T2 (Betraff)
DNA Test FAQ
Wat erkennt dësen DNA Test?
This DNA test detects the mutation associated with Androgen Insensitivity Syndrome In Thoroughbred Variant 2 (AIS-T2) in order to identify clear, carrier, or at-risk animals.
Firwat en Zuchtdier testen?
DNA Testen hëlleft Züchter méi sécher Maten ze plangen an de Risiko ze reduzéieren fir d'Mutatioun un d'Nofolger ze iwwerdroen.
Wat ass den Ierfschaftsmodus vun dësem Test?
Den Ierfschaftsmodus fir dësen Test gemellt ass X-Linked Recessive.
Wéi eng Mutatioun gëtt an dësem Test analyséiert?
This test analyses the mutation AR c.2132C/T.
Ass en Träger Déier onbedéngt betraff?
Net onbedéngt. D'Interpretatioun hänkt vum Ierfschaftsmuster an dem resultéierende Genotyp of.
Referenzen
Villagomez Daniel A F, Welsford Eastman G, King W Allan, Revay Tamas. Androgen Receptor Gene Variants in New Cases of Equine Androgen Insensitivity Syndrome. Genes (Basel). 2020 Jan 10;11(1):78. doi: 10.3390/genes11010078.